Uric Acid and Long-term Outcomes in CKD

Slides:

Advertisements

Similar presentations

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

Advertisements

Recent Advances in Traditional Chinese Medicine for Kidney Disease

CKD: Common, Harmful, and Treatable—World Kidney Day 2007

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,

Diagnosis and Treatment of Hyponatremia

Peritoneal dialysis American Journal of Kidney Diseases

Uric Acid as a Target of Therapy in CKD

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

Metabolic Complications in Elderly Adults With CKD

The Validity of Fractional Excretion of Uric Acid in the Diagnosis of Acute Kidney Injury Due to Decreased Kidney Perfusion George Kosmadakis, MD, Maria.

Quiz Page March 2008 American Journal of Kidney Diseases

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

Empirically Derived Search Filters for the Development of Kidney Disease Clinical Practice Guidelines Pavel S. Roshanov, MD, MSc, Arthur V. Iansavichus,

Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD

A Decade After the KDOQI CKD Guidelines

Sustainable Community-Based CKD Screening Methods Employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Peter A. McCullough,

What Is the Goal With Endogenous Filtration Markers—Estimation of GFR or Prediction of Kidney Outcomes? Andrew D. Rule, MD, MSc, Kent R. Bailey, PhD,

A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome

Evaluation of the Potential Living Kidney Donor

Hai-yan Wang, MD, American Journal of Kidney Diseases

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Salt and Hypertension American Journal of Kidney Diseases

Guidelines for the Older Adult With CKD

Lifetime Incidence of CKD Stages 3-5 in the United States

Effect of Protein Restriction on Serum and Urine Phosphate in the Modification of Diet in Renal Disease (MDRD) Study Britt Newsome, MD, Joachim H. Ix,

Cardiovascular Outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial Keith Norris, MD, Jacque Bourgoigne, MD, Jennifer.

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Nosratola D. Vaziri, MD American Journal of Kidney Diseases

Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS

A Decade After the KDOQI CKD Guidelines: A Historical Perspective

Usability Testing and Acceptance of an Electronic Medication Inquiry System for CKD Patients Clarissa J. Diamantidis, MD, MHS, Marni Zuckerman, MA, Wanda.

Polyunsaturated Fatty Acids and Kidney Disease

Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Nephrology: As It Was Then, But Is Not Now

Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)

Beef Tea, Vitality, Creatinine, and the Estimated GFR

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Evidence and Outcomes in CKD

Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD

Sulfamethoxazole Crystalluria

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Volume 68, Issue 2, Pages (August 2005)

Volume 62, Issue 6, Pages (December 2002)

Risk for Incident Renal Dialysis in a Managed Care Population

Cardiovascular risk factors in chronic kidney disease

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Arnold S. Relman, MD, American Journal of Kidney Diseases

Trial Quality in Nephrology: How Are We Measuring Up?

Removal of Dabigatran by Hemodialysis

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

Making Music American Journal of Kidney Diseases

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary Adam T. Whaley-Connell, DO, MSPH, Joseph.

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), Madhav V. Rao,

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD

Fetuin-A is not associated with mortality in chronic kidney disease

This Month in AJKD American Journal of Kidney Diseases

Dialysis Research and N-of-1 Trials: Made for Each Other?

Quiz Page January 2010 American Journal of Kidney Diseases

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

A Decade After the KDOQI CKD Guidelines: Impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Adam Whaley-Connell, DO, MSPH

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

Medication Adherence Behavior and Priorities Among Older Adults With CKD: A Semistructured Interview Study Dena E. Rifkin, MD, MS, M. Barton Laws, PhD,

Presentation transcript:

Uric Acid and Long-term Outcomes in CKD Magdalena Madero, MD, Mark J. Sarnak, MD, Xuelei Wang, MS, Tom Greene, PhD, Gerald J. Beck, PhD, John W. Kusek, PhD, Allan J. Collins, MD, Andrew S. Levey, MD, Vandana Menon, MD American Journal of Kidney Diseases Volume 53, Issue 5, Pages 796-803 (May 2009) DOI: 10.1053/j.ajkd.2008.12.021 Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Crude rates of clinical outcomes by uric acid tertiles. Abbreviation: CVD, cardiovascular disease. American Journal of Kidney Diseases 2009 53, 796-803DOI: (10.1053/j.ajkd.2008.12.021) Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions